Detection of clustered circulating tumor cells in early breast cancer

A recent "British Journal of Cancer" paper by the Aceto lab (IMHS) demonstrates the presence of highly metastatic circulating tumor cell clusters in patients with early breast cancer. These results highlight an important aspect of metastasis biology and the possibility to intervene early with anti-cluster therapeutics.

by Dominic Dähler
Figure Aceto paper
Using nanostructured titanium oxide-coated slides for shear-free CTC identification, CTC clusters are identified in the curative setting of patients with breast cancer.  

Circulating tumor cell (CTC) clusters have been proposed to be major players in the metastatic spread of breast cancer, particularly during advanced disease stages. Yet, it is unclear whether or not they manifest in early breast cancer, as their occurrence in patients with metastasis-free primary disease has not been thoroughly evaluated. In this study, exploiting nanostructured titanium oxide-coated slides for shear-free CTC identification, we detect clustered CTCs in the curative setting of multiple patients with early breast cancer prior to surgical treatment, highlighting their presence already at early disease stages. These results spotlight an important aspect of metastasis biology and the possibility to intervene with anti-cluster therapeutics already during the early manifestation of breast cancer.

Link to the paper in external pageBritish Journal of Cancer.

JavaScript has been disabled in your browser